Fidelity Investments
ORGO icon

Fidelity Investments’s Organogenesis Holdings ORGO Stock Holding History

Fidelity Investments’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$524K Sell
215,615
-160,200
-43% -$391K ﹤0.01% 3272
2026
Q1 		$891K Buy
375,815
+109,808
+41% +$380K ﹤0.01% 2912
2025
Q4 		$1.38M Buy
266,007
+24,828
+10% +$120K ﹤0.01% 2736
2025
Q3 		$1.02M Buy
241,179
+47,676
+25% +$222K ﹤0.01% 2793
2025
Q2 		$708K Sell
193,503
-44,160
-19% -$165K ﹤0.01% 2841
2025
Q1 		$1.03M Sell
237,663
-5,815
-2% -$23.5K ﹤0.01% 2667
2024
Q4 		$779K Buy
243,478
+69,883
+40% +$234K ﹤0.01% 2764
2024
Q3 		$496K Buy
173,595
+44,199
+34% +$124K ﹤0.01% 2859
2024
Q2 		$362K Buy
129,396
+44,744
+53% +$120K ﹤0.01% 2841
2024
Q1 		$240K Sell
84,652
-497
-0.6% -$1.69K ﹤0.01% 2973
2023
Q4 		$348K Sell
85,149
-1,149
-1% -$3.22K ﹤0.01% 2784
2023
Q3 		$274K Sell
86,298
-299
-0.3% -$950 ﹤0.01% 2782
2023
Q2 		$288K Buy
86,597
+83,527
+2,721% +$247K ﹤0.01% 2836
2023
Q1 		$6.54K Buy
3,070
+1,387
+82% +$3.43K ﹤0.01% 4298
2022
Q4 		$4.53K Sell
1,683
-1,024
-38% -$2.99K ﹤0.01% 4286
2022
Q3 		$9K Sell
2,707
-579
-18% -$2.62K ﹤0.01% 4125
2022
Q2 		$16K Sell
3,286
-8,939
-73% -$55K ﹤0.01% 3963
2022
Q1 		$93K Sell
12,225
-794,175
-98% -$6.15M ﹤0.01% 3475
2021
Q4 		$7.45M Buy
806,400
+43,400
+6% +$461K ﹤0.01% 2228
2021
Q3 		$10.9M Buy
+763,000
New +$11.8M ﹤0.01% 2097

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Fidelity Investments's ORGO Position: Q2 2026 in Review

Fidelity Investments reduced its Organogenesis Holdings (ORGO) stake by 43% in Q2 2026, selling an estimated $391K and leaving 215,615 shares worth $524K. The position accounts for ﹤0.01% of the portfolio, ranked #3272.

Fidelity Investments first reported a position in ORGO in Q3 2021 and has held it in 20 quarters since. The position peaked at $10.9M in Q3 2021. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Fidelity Investments held 215,615 shares of Organogenesis Holdings worth $524K as of Q2 2026.
  • Fidelity Investments sold 160,200 Organogenesis Holdings shares in Q2 2026, an estimated $391K.
  • Organogenesis Holdings made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #3272 holding.
  • Fidelity Investments first reported a position in Organogenesis Holdings in Q3 2021 and has held it in 20 quarters since.
  • Fidelity Investments's Organogenesis Holdings position peaked at $10.9M in Q3 2021.
  • 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.